Anti-PBM Value Position Rescription as a transparent, cost-saving alternative to traditional PBMs by emphasizing its subscription model and pass-through pricing that promises 70%+ savings and avoids rebate-driven incentives.

Enterprise Partnerships Highlight existing and potential health system and hospital partnerships (e.g., NewBridge Health collaboration) as proof points for employer-based drug program deployments and large-scale savings for employer groups.

Sourcing Strength Leverage capabilities in pharmacy networks, specialists, international sourcing, and 340B purchasing to target mid-market to enterprise employers seeking broad drug choice with aggressive pricing and expanded access.

Technology Enablement Pitch the AI-enabled software and cloud-based tech stack (AWS, Google Cloud, Sentry) as a differentiator for easy, understandable savings workflows, enabling faster ROI demonstrations to procurement and finance teams.

Market Momentum Use recent recognition and growth signals (press mentions, Excellent rating, Ready recognition) to build credibility with potential customers and frame Rescription as a growing, validated alternative to incumbents in the PBM space.